3 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo)Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, leiomyosarcoma, myomatous neoplasm, neoplasm, sarcomaActive, not recruitingPhase 32026-06-18NCT06088290
Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)Secondary Hemophagocytic Lymphohistiocytosis (sHLH)RecruitingPhase 2 / Phase 32026-05-26NCT05416307
BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid TumorsDNA Virus Infections, Digestive System Diseases, Digestive System Neoplasms, Infections, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Adipose Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Tumor Virus Infections, adenocarcinoma, carcinoma, cutaneous neuroendocrine carcinoma, epithelial neoplasm, hepatocellular carcinoma, liposarcoma, liver disorder, myxoid liposarcoma, myxoid/round cell liposarcoma, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, polyomavirus infectious disease, primitive neuroectodermal tumor, sarcoma, squamous cell lung carcinoma, viral infectious diseaseActive, not recruitingPhase 1 / Phase 22025-12-05NCT05120271